Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study
暂无分享,去创建一个
J. Rosenstock | A. Vinik | B. Goldstein | L. Porter | L. Porter | M. Freed | B. Kravitz | M. Heise | M. C. O'neill | R. Dirani | A. Vinik | B. J. Goldstein | A. I. Vinik | A. I. Vinik | R. G. Dirani